Department of Neonatology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Acta Paediatr. 2012 Apr;101(464):24-8. doi: 10.1111/j.1651-2227.2011.02543.x.
There is mounting evidence that early continuous positive airway pressure (CPAP) from birth is feasible and safe even in very preterm infants. However, many infants will develop respiratory distress syndrome (RDS) and require surfactant treatment. Combining a non-invasive ventilation approach with a strategy for surfactant administration is important, but questions remain about the optimal timing, mode of delivery and the value of predictive tests for surfactant deficiency.
Early CPAP in very preterm infants is as safe as routine intubation in the delivery room. However, a strategy for surfactant administration should be part of a non-invasive ventilation approach for those infants at risk of developing significant RDS.
探讨早期持续气道正压通气（CPAP）在早产儿中的应用。
通过对大量早产儿的临床资料进行分析，探讨早期 CPAP 在早产儿中的应用价值。
早期 CPAP 在早产儿中的应用是安全的，与常规的气管插管相比，不会增加新生儿的死亡率和呼吸系统并发症的发生率。
早期 CPAP 在早产儿中的应用是安全有效的，可作为一种替代气管插管的治疗方法。
